Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

ClinicalTrials.gov ID: NCT02876835

Public ClinicalTrials.gov record NCT02876835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa

Study identification

NCT ID
NCT02876835
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
3,872 participants

Conditions and interventions

Conditions

Interventions

  • Daprodustat Drug
  • Darbepoetin alfa Drug
  • Placebo Drug
  • Iron Therapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 26, 2016
Primary completion
Apr 18, 2021
Completion
Apr 18, 2021
Last update posted
Apr 1, 2024

2016 – 2021

United States locations

U.S. sites
161
U.S. states
34
U.S. cities
131
Facility City State ZIP Site status
GSK Investigational Site Andalusia Alabama 36420
GSK Investigational Site Birmingham Alabama 35249
GSK Investigational Site Huntsville Alabama 35805
GSK Investigational Site Glendale Arizona 85305
GSK Investigational Site Mesa Arizona 85202
GSK Investigational Site Phoenix Arizona 85016
GSK Investigational Site Phoenix Arizona 85027
GSK Investigational Site Scottsdale Arizona 48201
GSK Investigational Site Tucson Arizona 85745
GSK Investigational Site Azusa California 91702
GSK Investigational Site Bakersfield California 93308
GSK Investigational Site Bakersfield California 93309
GSK Investigational Site Chula Vista California 91910
GSK Investigational Site Cudahy California 90201
GSK Investigational Site El Centro California 92243
GSK Investigational Site Escondido California 92025
GSK Investigational Site Glendale California 91204
GSK Investigational Site Granada Hills California 91344
GSK Investigational Site La Mesa California 91942
GSK Investigational Site La Palma California 90623
GSK Investigational Site Long Beach California 90806
GSK Investigational Site Los Angeles California 90022
GSK Investigational Site Los Angeles California 90095
GSK Investigational Site Montebello California 90640
GSK Investigational Site National City California 91950
GSK Investigational Site Riverside California 92505
GSK Investigational Site San Diego California 92103
GSK Investigational Site San Diego California 92111
GSK Investigational Site San Luis Obispo California 93405
GSK Investigational Site Simi Valley California 93065
GSK Investigational Site Tarzana California 91356
GSK Investigational Site Whittier California 90602
GSK Investigational Site Middlebury Connecticut 06762
GSK Investigational Site Washington D.C. District of Columbia 20037
GSK Investigational Site Aventura Florida 33180
GSK Investigational Site Boca Raton Florida 33431
GSK Investigational Site Coral Gables Florida 33134
GSK Investigational Site Cutler Bay Florida 33189
GSK Investigational Site Doral Florida 33122
GSK Investigational Site Fort Lauderdale Florida 33308
GSK Investigational Site Homestead Florida 33033
GSK Investigational Site Hudson Florida 34667
GSK Investigational Site Jacksonville Florida 32224
GSK Investigational Site Jacksonville Florida 32256
GSK Investigational Site Lauderdale Lakes Florida 33313
GSK Investigational Site Miami Florida 33126
GSK Investigational Site Miami Florida 33143
GSK Investigational Site Miami Florida 33145
GSK Investigational Site Miami Florida 33147
GSK Investigational Site Miami Florida 33150
GSK Investigational Site Miami Florida 33155
GSK Investigational Site Miami Florida 33156
GSK Investigational Site Miami Florida 33165
GSK Investigational Site Miami Florida 33169
GSK Investigational Site Miami Florida 33173
GSK Investigational Site Miami Gardens Florida 33169
GSK Investigational Site Miami Lakes Florida 33014
GSK Investigational Site Ocala Florida 34471
GSK Investigational Site Orlando Florida 32810
GSK Investigational Site Pembroke Pines Florida 33028
GSK Investigational Site Port Charlotte Florida 33952
GSK Investigational Site South Miami Florida 33143
GSK Investigational Site Tampa Florida 33612
GSK Investigational Site Temple Terrace Florida 33637
GSK Investigational Site Atlanta Georgia 30342
GSK Investigational Site Augusta Georgia 30904
GSK Investigational Site Augusta Georgia 30909
GSK Investigational Site Augusta Georgia 30912
GSK Investigational Site Columbus Georgia 31904
GSK Investigational Site Nampa Idaho 83687
GSK Investigational Site Chicago Illinois 60611
GSK Investigational Site Chicago Illinois 60643
GSK Investigational Site Crystal Lake Illinois 60014
GSK Investigational Site Mount Prospect Illinois 60056
GSK Investigational Site Quincy Illinois 62301
GSK Investigational Site Springfield Illinois 62702
GSK Investigational Site Fort Wayne Indiana 46845
GSK Investigational Site Jeffersonville Indiana 47130
GSK Investigational Site Michigan City Indiana 46360
GSK Investigational Site Des Moines Iowa 50309
GSK Investigational Site Iowa City Iowa 52242
GSK Investigational Site Hutchinson Kansas 67502
GSK Investigational Site Wichita Kansas 67214
GSK Investigational Site Louisville Kentucky 40202
GSK Investigational Site Baton Rouge Louisiana 70808
GSK Investigational Site Baton Rouge Louisiana 70836
GSK Investigational Site Metairie Louisiana 70006
GSK Investigational Site Baltimore Maryland 21287
GSK Investigational Site Potomac Maryland 20854
GSK Investigational Site Takoma Park Maryland 20912-6385
GSK Investigational Site Boston Massachusetts 02114
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Kalamazoo Michigan 49007
GSK Investigational Site Pontiac Michigan 48341
GSK Investigational Site Minneapolis Minnesota 55414
GSK Investigational Site Jackson Mississippi 39216
GSK Investigational Site Tupelo Mississippi 38801
GSK Investigational Site St Louis Missouri 63106
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site North Platte Nebraska 69101
GSK Investigational Site Las Vegas Nevada 89106
GSK Investigational Site Brooklyn New York 11203
GSK Investigational Site Buffalo New York 14215
GSK Investigational Site Flushing New York 11355
GSK Investigational Site Laurelton New York 11413
GSK Investigational Site New York New York 10021
GSK Investigational Site New York New York 10029
GSK Investigational Site Ridgewood New York 11385
GSK Investigational Site The Bronx New York 10461
GSK Investigational Site The Bronx New York 10467
GSK Investigational Site Yonkers New York 10704
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Raleigh North Carolina 27609
GSK Investigational Site Rocky Mount North Carolina 27804
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Grand Forks North Dakota 58201
GSK Investigational Site Canton Ohio 15212
GSK Investigational Site Cincinnati Ohio 45206
GSK Investigational Site Cincinnati Ohio 45220
GSK Investigational Site Mentor Ohio 44060
GSK Investigational Site Lawton Oklahoma 73505
GSK Investigational Site Portland Oregon 97210
GSK Investigational Site Roseburg Oregon 97471
GSK Investigational Site Bethlehem Pennsylvania 18017
GSK Investigational Site Doylestown Pennsylvania 18901
GSK Investigational Site Lancaster Pennsylvania 17601
GSK Investigational Site Upland Pennsylvania 19013
GSK Investigational Site Wyomissing Pennsylvania 19610
GSK Investigational Site Anderson South Carolina 29621
GSK Investigational Site Charleston South Carolina 29425
GSK Investigational Site Columbia South Carolina 29209
GSK Investigational Site Sumter South Carolina 29150
GSK Investigational Site Cordova Tennessee 38018
GSK Investigational Site Knoxville Tennessee 37923
GSK Investigational Site Memphis Tennessee 38163
GSK Investigational Site Nashville Tennessee 37205
GSK Investigational Site Arlington Texas 76002
GSK Investigational Site Austin Texas 78751
GSK Investigational Site Austin Texas 78758
GSK Investigational Site Corpus Christi Texas 78404
GSK Investigational Site Corsicana Texas 75110
GSK Investigational Site Dallas Texas 75237
GSK Investigational Site Dallas Texas 75246
GSK Investigational Site Houston Texas 77004
GSK Investigational Site Houston Texas 77043
GSK Investigational Site Houston Texas 77084
GSK Investigational Site Houston Texas 77099
GSK Investigational Site Lufkin Texas 75904
GSK Investigational Site McAllen Texas 78503
GSK Investigational Site San Antonio Texas 78202
GSK Investigational Site San Antonio Texas 78212
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site San Antonio Texas 78258
GSK Investigational Site Temple Texas 76508
GSK Investigational Site Waxahachie Texas 75165
GSK Investigational Site Alexandria Virginia 22304
GSK Investigational Site Fairfax Virginia 22033
GSK Investigational Site Hampton Virginia 23666
GSK Investigational Site Salem Virginia 24153
GSK Investigational Site Bluefield West Virginia 24701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 413 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02876835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02876835 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →